Last reviewed · How we verify

NCT07140289

Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying

ENROLLING BY INVITATION Last updated 3 September 2025
What this trial tests

trial testing Ultrasound of gastric contents in Gastric Emptying in 100 participants. Enrolling by invitation.

Timeline
1 September 2025
Primary endpoint
1 June 2027
1 June 2028

Quick facts

Lead sponsorWael Saasouh, MD
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment100
Start date1 September 2025
Primary completion1 June 2027
Estimated completion1 June 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Wael Saasouh, MD

Who can join

Adults 18 to 90, any sex, with Gastric Emptying or Glucagon-Like Peptide-1 Receptor Agonists. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the effect of using Glucagon-like peptide-1 receptor agonists (GLP-1) receptor agonists on gastric emptying on surgical patients and whether specific guidelines need to be established for these patients. GLP-1 receptor agonists are mainly used for the treatment and mitigation of obesity and metabolic syndromes. One of their mechanisms of action is by delaying gastric emptying, hence increasing satiety. However, patients need to abstain from eating for a set amount of time before surgery to reduce the risk of aspiration. Hence patients who use GLP-1 receptor agonists may need more time to abstain eating (nil-per-os). In this study we aim to assess how much time is sufficient before surgery in these specific population of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gastric Emptying

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07140289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing